In silico studies of phytoconstituents to identify potential inhibitors for erα protein of breast cancer

Simple item page
dc.contributor.authorMurugesan, Sankaranarayanan
dc.date.accessioned2025-03-10T09:20:44Z
dc.date.available2025-03-10T09:20:44Z
dc.date.issued2025-02
dc.description.abstractIt is noteworthy that a wide array of plants and nutraceuticals are effectively utilized in the treatment of various cancers, demonstrating potent effects on different cancer targets with fewer side effects. Notably, estrogen alpha has been identified as a crucial factor in breast cancer cell proliferation. Agents that can antagonize its action hold promise as potential drug leads for the treatment of breast cancer.en_US
dc.identifier.urihttps://www.benthamdirect.com/content/journals/mc/10.2174/0115734064301748240821081206
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18240
dc.language.isoenen_US
dc.publisherBentham Scienceen_US
dc.subjectPharmacyen_US
dc.subjectADME(T)en_US
dc.subjectBreast canceren_US
dc.subjectDrug developmenten_US
dc.subjectMD analysisen_US
dc.subjectMolecular dockingen_US
dc.subjectNutraceuticalsen_US
dc.titleIn silico studies of phytoconstituents to identify potential inhibitors for erα protein of breast canceren_US
dc.typeArticleen_US

Files

Collections

Department of Pharmacy